| Tag | Content |
|---|
EnhancerAtlas ID | HS162-05570 |
Organism | Homo sapiens |
Tissue/cell | Plasma_cell_myeloma |
Coordinate | chr2:88899280-88901310 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| FOS | MA0476.1 | chr2:88899850-88899861 | AATGAGTCACC | - | 6.02 | | FOSL2 | MA0478.1 | chr2:88899851-88899862 | ATGAGTCACCC | - | 6.14 | | JUNB | MA0490.1 | chr2:88899851-88899862 | ATGAGTCACCC | - | 6.32 | | JUND(var.2) | MA0492.1 | chr2:88899802-88899817 | GATGACATCACCCTT | - | 6.36 |
|
| | Number of super-enhancer constituents: 7 | ID | Coordinate | Tissue/cell |
| SE_10491 | chr2:88896321-88901421 | CD19_Primary | | SE_11125 | chr2:88893822-88930665 | CD20 | | SE_43929 | chr2:88898967-88901309 | MM1S | | SE_58772 | chr2:88890746-88928380 | Ly1 | | SE_60725 | chr2:88890414-88928580 | DHL6 | | SE_61864 | chr2:88897269-88910421 | Toledo | | SE_62662 | chr2:88894659-88928826 | Tonsil |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I088598 | chr2 | 88898411 | 88902917 |
|
Enhancer Sequence | CTCTAAAGCA GTAGCGGGTC CTTAGGGAAT ACAATGTCTC CTAAGTGCAA AAATCAACTG 60
CCAAACTAAT ATGAAATAGA ATCCATTTTT GCCCTAAGGA TGGTCTCTGC AACTCCAAAA 120
GTAAAACCAG CCAATCAACC AACAGACTGA CCAACCAACC TTATCTTCAA TTAAAAATAT 180
AGTTTAAAGA TTCAAGATTT GATATCATTG ACCATACTGA GAAAACTTCC TTATTTTAAA 240
AGTTAAATGC TCAACAGCAT TAACTCAGTA AGTGCAAAAC ACAAAACAAC AACAAGGCAT 300
TATGATTCAA TAATGAATCA TCATGTCATA TTTCTGGATT GTGATTTTAA AAGTTCACTT 360
TTAAATAGCT GCTCTTCGCT AATTGGTTGC TTATGAGTCA TACACATGGC TGCTGACCTT 420
TGTGCCAATC TTGTCAAGTC TTTCAGGCTG CATATGTGAA AGCAGATGGA GCTTTTCCTT 480
GAGAGCCACA GAAGCAATAT ATGCATGCAG TTCAGGTACA GAGATGACAT CACCCTTCAC 540
AATAGCATTA CCTCACCCCC TAAGCATAGG AATGAGTCAC CCGATAGTCA GCTGCAAATC 600
TCTTGGTAGA AAAAAATGTA GGTTACGGTG ATGCATTTTC ACATCCCACT GATTTGTTCA 660
TGTAAGCAGC TATTTGTTCT GATTCGCTGC TCTGCATCTC AAACTTATTG TGTGACTTGC 720
TTCTCCCTTA AGTCATTTTA AAAAGTCTAA ATTTTTGTAT TTATTTTCTT TATTGTTTTT 780
TCCCTGTTCA TAATTTAAAA TAAAAGGTGC TAGCAAACTC CCAGAGTCTA TCTGTGTAAT 840
CATAAAGCAG TTTAGTAAAG TAATTCCGTT TCTGTTTCTT AACAAAACCT AAGTGGTACA 900
ATGAATACCA GTGGCACTTG CAATCAGGGA CTTCTATCTG AAATTAAAAT GTGAAAATAA 960
CTTTAATTTT AAAGTGGAGG AAGGAATTTC ATATGAGAAA ATAAAGGAAG TACTACTACT 1020
AAAATGAGCA CTACCAGCAT TAAAAAACAA AAATTCCTCT AACCATAAGA AAAAATGTTT 1080
TCCATTTGAT TCTTCCCTAT TTTTCTATGC AGCCAACCCC TCTCCCCAAC TGACTCACAC 1140
ACTTTTTGGA GTACATTCAA CTTTATTTTA ACTGGTTATA AAAAATTTCA AGCATATAGA 1200
ATGTGGAGAT TAATAAATCC CCATGTATCT ATCATCCAGT TCCAACAATT ATCAACATTT 1260
TGCCAACTGT TTCATCTATC TCCACTCACC TACTATATAC TTGTTTACTG GAGTAAAATC 1320
ATCAAATTTT AAAATTTCTC CTATTATCTC AAAGATCTAC TTTATGATGA GGAATTCCAA 1380
GTCTACATAT TACATCTGAT TCTTTTCCCT CCACAAAGGA ACTTCTTTCA ACCCCTTTGT 1440
TATGCACTGA TTTACTTGAG AAACCAGATT ATCTGTCCTA TAGAATGTCC CACAGTCAGG 1500
ATTCTACATG TCATTTAACT TGTTCCTTTA TTTCCTATAT TTCCTGAAAA GTATGATTAG 1560
ACTTGGAGCT TTGATCTGAT GCAGGTTCAG TTGTTTTGAC AAGAAGCCTT CGTATCTGGT 1620
GCTACGCACT TCCTATTACA TTAGGGGTCT ACAAACTACA GCCCATGAGC CAAATCCAGC 1680
CTAATGCCTG TTTTGTAAGA AAAGTTTTAT TGGAACACAG CCACACATTC ATTCATTTAT 1740
GTATCTGTCT ATGACTGCTT TCCAGCTGCA ACTAAAGGCC ACATGATCCT CAAAGCCTAA 1800
GATAAGCACC ATCTGGCCCT TTACAGGAAA AGTTTGCTGG CCCCTATGCT ATACCATATT 1860
AGGAGGCACA TAGTGTTTGC ATGCCCCACT TTTAATGATG TTACTATCAA TCACTTGAGT 1920
TTGGGGGAGT CAGCCTGATC CCTCCATTTA AAGTGTCCCA TCAACTTTTT ACCATTTTAG 1980
TATTGCTTGA TGGCCTACTA TTTCAATAAA AGAACTAGAA TAGCAATTTC 2030
|
